Showing results (41-50 of 289) with videos related to
Sort By:
Pageof 29
Blood Advances|May 25, 2022
HLA-matching with PTCy: a reanalysis of a CIBMTR dataset with propensity score matching and donor ageAlexander Ambinder, Tania Jain, Hua-Ling Tsai, et al.Transplantation and Cellular Therapy|December 1, 2022
Factors Associated with Opting Out of Donation among Registered Young Unrelated Hematopoietic Stem Cell DonorsAhmed B Hamed, Jessica G Bruce, Vidya Kuniyil, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 7, 2012
Graft-versus-host disease induced graft-versus-leukemia effect: greater impact on relapse and disease-free survival after reduced intensity conditioningDaniel Weisdorf, Mei-Jie Zhang, Mukta Arora, et al.Transplantation and Cellular Therapy|March 19, 2022
Racial and Ethnic Differences in Attitudes, Perceptions, and Knowledge about Unrelated Hematopoietic Stem Cell Donation: A Study of Younger Newly Recruited Potential DonorsAhmed B Hamed, Jessica G Bruce, Vidya Kuniyil, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 20, 2010
Assessing surge capacity for radiation victims with marrow toxicityMatthew S Davids, Cullen Case, Raymond Hornung, et al.Blood|January 12, 2013
Mapping MHC haplotype effects in unrelated donor hematopoietic cell transplantationEffie W Petersdorf, Mari Malkki, Mary M Horowitz, et al.Transplantation and Cellular Therapy|February 16, 2024
Factors Associated with Opting Out of an Unrelated Hematopoietic Stem Cell Donor Registry: Differences and Similarities across Five Key Groups of Young Race/Ethnically Diverse Potential Donors in the United StatesAhmed B Hamed, Jessica G Bruce, Vidya Kuniyil, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 26, 2016
Recovery of Unrelated Donors of Peripheral Blood Stem Cells versus Recovery of Unrelated Donors of Bone Marrow: A Prespecified Analysis from the Phase III Blood and Marrow Transplant Clinical Trials Network Protocol 0201Linda J Burns, Brent R Logan, Pintip Chitphakdithai, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 27, 2019
Role of Race/Ethnicity in Donor Decisions about Unrelated Hematopoietic Progenitor Cell Donation: Exploring Reasons for Higher Attrition among Racial/Ethnic MinoritiesChloe Anthias, Bronwen E Shaw, Jessica G Bruce, et al.British Journal of Haematology|May 19, 2004
Validation and extension of the EBMT Risk Score for patients with chronic myeloid leukaemia (CML) receiving allogeneic haematopoietic stem cell transplantsJakob R Passweg, Irwin Walker, Kathleen A Sobocinski, et al.Pageof 29